Read this article:
http://www.techrevie...ffman020105.asp
One of the reasons that so many starry-eyed genome-related startups failed was due to the fact that that genomic discoveries are still significantly removed from actual metabolic chemistry, which is mainly under the regime of proteins. Could the advent of proteomic deconstruction then be what's necessary to bring private industry within striking distance of a goldrush and renewed mass commercial involvement in the molecular biology frontier?
Hmm, with server-farmers like Google branching into all sorts of new arenas, I wonder if even they might somehow move into the protein grid?
Woo, note that nifty phrase Systems Biology again here. I like this whole approach of justifying/rectifying medicine thru physics, through complex informational modeling. If it can be done for the stock market, then it can and should be done for the human body.
From what I can see, we really need to see the lab-on-a-chip devices take off, to bridge the critical gap between information systems and the real world of wet biology. Once that gap can be bridged and the 2 worlds mated, then it will be possible to rapidly accelerate investigation and decompilation of our wonderful and mysterious metabolism.
Comments?